THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0

作者：

Liguori, A. ^{[1
]}

D'Ambrosio, F. ^{[2
]}

Nicholas, V. ^{[1
]}

Termite, F. ^{[1
]}

Petrucci, L. ^{[1
]}

Beschi, R. ^{[1
]}

Orienti, M. ^{[2
]}

Galletti, S. ^{[2
]}

Cardinali, S. ^{[2
]}

Riccardi, L. ^{[1
]}

Pizzolante, F. ^{[1
]}

De, Matthaeis N. ^{[1
]}

Zocco, M. A. ^{[1
]}

Giustiniani, M. C. ^{[3
]}

Marrone, G. ^{[1
]}

Biolato, M. ^{[1
]}

Cefalo, C. ^{[1
]}

Vecchio, F. M. ^{[3
]}

Pompili, M. ^{[1
]}

Rapaccini, G. L. ^{[1
]}

Grieco, A. ^{[1
]}

Urbani, A. ^{[2
]}

Sanguinetti, M. ^{[2
]}

Gasbarrini, A. ^{[1
]}

Miele, L. ^{[1
]}

机构：

[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Traslat Med & Surg, Rome, Italy

[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Lab & Infect Sci, Rome, Italy

[3] Fdn Policlin Univ A Gemelli IRCCS, Dept Women Children & Publ Hlth Sci, Rome, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

T.07.5

引用

页码：S257 / S257

页数：1

共 50 条

[1] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Liu, Huan
Yerevanian, Armen
Westerhoff, Maria
Hastings, Margaret H.
Guerra, Justin Ralph Baldovino
Zhao, Meng
Svensson, Katrin J.
Cai, Bishuang
Soukas, Alexander A.
Rosenzweig, Anthony
[J]. DIABETES, 2024, 73 (02) : 260 - 279
[2] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Kasprzak-Drozd, Kamila
Nizinski, Przemyslaw
Kasprzak, Paulina
Kondracka, Adrianna
Oniszczuk, Tomasz
Rusinek, Agata
Oniszczuk, Anna
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
[3] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Shin, Soyeon
Kim, Jaeyoung
Lee, Ju Yeon
Kim, Jun
Oh, Chang-Myung
[J]. JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
[4] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Elshaer, Amani
Chascsa, David M. H.
Lizaola-Mayo, Blanca C.
[J]. LIFE-BASEL, 2024, 14 (07):
[5] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Chan, Wah-Kheong
Chuah, Kee-Huat
Rajaram, Ruveena Bhavani
Lim, Lee-Ling
Ratnasingam, Jeyakantha
Vethakkan, Shireene Ratna
[J]. JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
[6] The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis
Venkatesan, Nanditha
Doskey, Luke C.
Malhi, Harmeet
[J]. AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (12): : 1887 - 1899
[7] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
Sallam, Sandy
Ahmed, Aijaz
Gu, Xin
[J]. DIABETES, 2024, 73
[8] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Polyzos, Stergios A.
Targher, Giovanni
[J]. CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
[9] Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
Sanyal, Arun J.
Husain, Mansoor
Diab, Crystel
Mangla, Kamal Kant
Shoeb, Ahsan
Lingvay, Ildiko
Tapper, Elliot B.
[J]. AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 41
[10] Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)
van Son, Koen C.
van Dijk, Anne-Marieke
Driessen, Stan
Mak, Anne Linde
Witjes, Julia J.
Houttu, Veera A. T.
Zwirs, Diona
Nieuwdorp, Max
van den Born, Bert-Jan H.
Fischer, Johan C.
Tushuizen, Maarten E.
Drenth, Joost P. H.
Hamer, Henrike M.
Beuers, Ulrich H. W.
Verheij, Joanne
Holleboom, Adriaan Georgius
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024,

← 1 2 3 4 5 →